212010-22-5

Upstream product

• 3886-69-9 (R)-1-phenyl-ethyl-amine 
• 5711-41-1 3-(4-methoxybenzoyl)acrylic acid 
• 20972-37-6 (E)-4-(4-methoxyphenyl)-4-oxo-2-butenoic acid 

Downstream Products

• 1273329-15-9 (1R,3R)-N-(3-hydroxy-1-hydroxymethyl-3-(4-methoxyphenyl)prop-1-yl)dodecanamide 
• 1213844-02-0 (1R,3R)-3-amino-1-(4-methoxyphenyl)butane-1,4-diol 
• 1273328-92-9 (1R,3R)-1-(4-methoxyphenyl)-3-((R)-1-phenylethylamino)butane-1,4-diol 
• 82310-97-2 (R)-2-amino-4-(4-methoxyphenyl)butanoic acid 
• 861896-93-7 (2R,4R)-4-hydroxy-4-(4-methoxyphenyl)-2-{[(1R)-1-phenylethyl]amino}butanoic acid 
• 861896-86-8 (2R,4S)-4-hydroxy-4-(4-methoxyphenyl)-2-{[(1R)-1-phenylethyl]amino}butanoic acid 

Relevant academic research and scientific papers

A novel β-amino acid in cytotoxic peptides from the cyanobacterium Tychonema sp.

The cyclic dodecapeptides tychonamide A (1) and B (2) isolated from the methanolic extract of the cyanobacterium Tychonema sp. contain the novel β-amino acid 3-amino-2,5,7-trihydroxy-8-phenyloctanoic acid (Atpoa). Compounds 1 and 2 have cytotoxic activity

Crystallization-induced asymmetric transformations (CIAT): Stereoconvergent acid-catalyzed lactonization of substituted 2-amino-4-aryl-4-hydroxybutanoic acids

Acid-catalyzed lactonization in dilute hydrochloric acid of N-substituted 2-amino-4-aryl-4-hydroxybutanoic acids with electron donating aryl substituents is stereoconvergent. The stereochemical outcome is controlled by the precipitation of little soluble